top of page
gradientForSurfBreak.png

Item List

Strados Labs
Strados Labs Announces Pediatric Asthma Study to Validate its Wearable Device in Children with Wheeze

Strados Labs has partnered with Ann & Robert H. Lurie Children’s Hospital of Chicago for a clinical trial to evaluate the effectiveness of its RESP™ Biosensor in children presenting with wheeze. The RESP™ Biosensor – a novel wearable device used to remotely monitor lung sounds for asthma symptoms such as coughing and wheezing – will be evaluated against a 3M™ Littman digital stethoscope used for episodic auscultation.

Recent Posts

Portfolio Company

Carlsmed.png

Matterworks Announces Updates to Leadership Team ...

PR Newswire

Portfolio Company

Carlsmed.png

Mother Goose Health Partners with Nest Collaborative and Introduce its Ground Br ...

CIO Review

Portfolio Company

Carlsmed.png

UptimeHealth Announces Acquisition of Dental Whale, Including its Subsidiaries D ...

Businesswire

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page